Could a simple diet cut hospital stays after lung surgery by 30%?
NCT ID NCT07159659
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a medium-chain triglyceride (MCT) diet, given after lung resection surgery, can help people leave the hospital sooner. The diet bypasses the lymphatic system, potentially reducing fluid buildup and complications. Researchers will compare hospital stay length and recovery in 210 adults undergoing lung surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- medium-chain triglyceride (MCT) diet
- What this could lead to
- If it works, this diet could shorten hospital stays and speed recovery after lung surgery, reducing healthcare costs and patient discomfort.
- What could go wrong
- This is a small, early-stage trial with only 210 participants. The diet may not significantly reduce hospital stay, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THORACIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prince of Wales Hospital
RECRUITINGShatin, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immunotherapy cocktail shrink inoperable lung tumors?
- Could everyday heart drugs shield cancer patients from Radiation's cardiac toll?
- New combo tackles back pain from spine tumors
- Targeted pill shows promise for rare lung cancer, but trial stopped early
- Could a simple injection cut opioid use after lung surgery?
- 7,000 patients join tissue bank to unlock secrets of lung disease